Epix to form technology advisory board

By AuntMinnie.com staff writers

August 14, 2008 -- MRI contrast developer Epix Pharmaceuticals has formed a technology advisory board to help the company with its in silico modeling drug discovery platform, the Lexington, MA-based company said.

Board members include the following:

Charles Brooks, Ph.D., a Warner-Lambert/Parke-Davis professor of chemistry and a professor of biophysics in the Department of Chemistry at the University of Michigan
Johan Aqvist, Ph.D., a professor of theoretical chemistry in the Department of Cell and Molecular Biology at Uppsala University, Sweden
Gabriele Cruciani, Ph.D., a professor of organic chemistry and cheminformatics in the Laboratory for Chemometrics and Cheminformatics at the University of Perugia, Italy